InsiderTrades

Form 4 for CVS CVS Health

Accepted 2021-11-05 00:00:00 ET · period of report 2021-11-03 · accession 0001127602-21-028481 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-11-05 2021-11-03 CVS Roberts Jonathan C EVP, COO M - OptEx $45.93 +108.9K 216.0K +102% +$5.00M
D 2021-11-05 2021-11-03 CVS Roberts Jonathan C EVP, COO S - Sale+OE $95.00 -108.9K 107.1K -50% -$10.34M
D 2021-11-05 2021-11-03 CVS Roberts Jonathan C EVP, COO M - OptEx $0.00 -108.9K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-11-03 M A 108,870 $45.93 215,984.72 D — —
2 Common Common Stock 2021-11-03 S D 108,870 $95.00 107,114.72 D — —
3 Derivative Stock Option 2021-11-03 M D 108,870 $0.00 0 D $45.93 · 2015-09-04 to 2022-09-04 108,870 Common Stock (F2) Option became exercisable in three equal annual installments, commencing 9/4/2015.